v3.22.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in- Capital
Additional Paid-in- Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Beginning Balance at Dec. 31, 2019 $ 497,481   $ 172,662 $ 25,014   $ (5,698) $ 0 $ 305,503  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 97,061             97,061  
Dividends declared (24,202)             (24,202)  
Other comprehensive loss, net of tax (354)         (354)      
Share repurchases under buyback program (23,106)   (4,331) (627)       (18,148)  
Issuance of shares upon exercise of common stock options 643   643            
Repurchase of shares for tax payments related to the vesting and exercise of share-based grants (4,042)   (4,042)            
Stock-based compensation expense 15,960   15,960            
Ending Balance at Dec. 31, 2020 $ 559,441   180,892 24,387   (6,052) 0 360,214  
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06 [Member]                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income $ 224,915             224,915  
Dividends declared (27,836)             (27,836)  
Other comprehensive loss, net of tax 3,824         3,824      
Share repurchases under buyback program (48,940)   (2,729) (368)     (21,550) (24,293)  
Issuance of shares upon exercise of common stock options 4,950   4,950            
Repurchase of shares for tax payments related to the vesting and exercise of share-based grants (17,815)   (17,815)            
Stock-based compensation expense 22,887   22,887            
Retirement of treasury stock 0   (2,013) (271)     21,550 (19,266)  
Issuance of shares in connection with a business combination 10,211   10,211            
Purchase of convertible notes hedges, net of tax of $14,556 (42,887)     (42,887)          
Proceeds from sale of warrants 43,677     43,677          
Equity component of convertible note issuance, net of tax of $11,923 35,130     35,130          
Ending Balance at Dec. 31, 2021 767,557 $ (43,693) 196,383 59,668 $ (59,668) (2,228) 0 513,734 $ 15,975
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 328,196             328,196  
Dividends declared (33,160)             (33,160)  
Other comprehensive loss, net of tax 1,533         1,533      
Share repurchases under buyback program (76,983)   (11,099)         (65,884)  
Issuance of shares upon exercise of common stock options 195   195            
Repurchase of shares for tax payments related to the vesting and exercise of share-based grants (10,227)   (10,227)            
Stock-based compensation expense 21,751   21,751            
Ending Balance at Dec. 31, 2022 $ 955,169   $ 197,003 $ 0   $ (695) $ 0 $ 758,861